Cargando…

EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer

Forkhead Box O3 (FOXO3) is a tumor suppressor whose activity is fine-tuned by post-translational modifications (PTMs). In this study, using the BT474 breast cancer cells and a recently established lapatinib resistant (BT474-Lap(R)) cell line, we observed that higher FOXO3 and acetylated (Ac)-FOXO3 l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmud, Zimam, Gomes, Ana R., Lee, Hee Jin, Aimjongjun, Sathid, Jiramongkol, Yannasittha, Yao, Shang, Zona, Stefania, Alasiri, Glowi, Gong, Gyungyub, Yagüe, Ernesto, Lam, Eric W.-F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721388/ https://www.ncbi.nlm.nih.gov/pubmed/31357743 http://dx.doi.org/10.3390/cancers11081067

Ejemplares similares

Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation
por: Aimjongjun, Sathid, et al.
Publicado: (2019)

Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells
por: Alasiri, Glowi, et al.
Publicado: (2019)

Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-FOXO3 axis to modulate cancer drug resistance and clonal survival
por: Alasiri, Glowi, et al.
Publicado: (2020)

FOXO transcription factor family in cancer and metastasis
por: Jiramongkol, Yannasittha, et al.
Publicado: (2020)

Lectin affinity chromatography and quantitative proteomic analysis reveal that galectin-3 is associated with metastasis in nasopharyngeal carcinoma
por: Aimjongjun, Sathid, et al.
Publicado: (2020)

Comprehensive Analysis of KCNJ14 Potassium Channel as a Biomarker for Cancer Progression and Development
por: Alasiri, Glowi
Publicado: (2023)

FOXA1 is a determinant of drug resistance in breast cancer cells
por: Kumar, Uttom, et al.
Publicado: (2021)

EP300 promotes ferroptosis via HSPA5 acetylation in pancreatic cancer
por: Wang, Yuan, et al.
Publicado: (2023)

Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
por: Asaduzzaman, Muhammad, et al.
Publicado: (2017)

Temporal Variations in Patterns of Clostridioides difficile Strain Diversity and Antibiotic Resistance in Thailand
por: Wongkuna, Supapit, et al.
Publicado: (2021)

p300 arrests intervertebral disc degeneration by regulating the FOXO3/Sirt1/Wnt/β‐catenin axis
por: Hao, Yingjie, et al.
Publicado: (2022)

High Glucose Induced Alteration of SIRTs in Endothelial Cells Causes Rapid Aging in a p300 and FOXO Regulated Pathway
por: Mortuza, Rokhsana, et al.
Publicado: (2013)

N(1)-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation
por: Zhang, Jingfan, et al.
Publicado: (2020)

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2018)

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021)

Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation
por: Luo, Mayao, et al.
Publicado: (2023)

Cooperative effects of SIRT1 and SIRT2 on APP acetylation
por: Li, Na, et al.
Publicado: (2023)

miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation
por: Zhang, Mei, et al.
Publicado: (2017)

NEDDylation negatively regulates ERRβ expression to promote breast cancer tumorigenesis and progression
por: Naik, Sanoj K., et al.
Publicado: (2020)

Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket
por: Sundriyal, Sandeep, et al.
Publicado: (2017)

Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015)

EP300 Protects from Light-Induced Retinopathy in Zebrafish
por: Kawase, Reiko, et al.
Publicado: (2016)

Aspirin induces autophagy via inhibition of the acetyltransferase EP300
por: Castoldi, Francesca, et al.
Publicado: (2018)

Directional divergence of Ep300 duplicates in teleosts and its implications
por: Wang, Xianzong, et al.
Publicado: (2020)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
por: Yang, Lei, et al.
Publicado: (2023)

EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs
por: Rubio, Karla, et al.
Publicado: (2023)

Development of a yeast model to study the contribution of vacuolar polyphosphate metabolism to lysine polyphosphorylation
por: Azevedo, Cristina, et al.
Publicado: (2020)

Control of Foxo1 Gene Expression by Co-activator P300
por: Wondisford, Anne R., et al.
Publicado: (2014)

FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation
por: Wang, Xiaowei, et al.
Publicado: (2021)

Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016)

Analysis of acetylation stoichiometry suggests that SIRT3 repairs nonenzymatic acetylation lesions
por: Weinert, Brian T, et al.
Publicado: (2015)

Phosphorylation and acetylation modifications of FOXO3a: Independently or synergistically?
por: Wang, Xianwang, et al.
Publicado: (2017)

FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
por: Park, Jinju, et al.
Publicado: (2018)

EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019)

EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma
por: Durbin, Adam D., et al.
Publicado: (2022)

The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
por: Zhu, Yu, et al.
Publicado: (2023)

Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors
por: Crawford, McKenna C., et al.
Publicado: (2023)

Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1
por: Maiese, Kenneth
Publicado: (2020)

SIRT1/FOXO Signaling Pathway in Breast Cancer Progression and Metastasis
por: Dilmac, Sayra, et al.
Publicado: (2022)

Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3
por: Parodi-Rullán, Rebecca M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e0hpj247oebduo62sq9c4khhq1